CDK6 and gastric cancer: For example, enhanced expression of miR-29a can inhibit mucin 1 (MUC1), reducing the expression levels of cell cycle-dependent kinases CDK2, CDK4, and CDK6, leading to reduced proliferation of gastric cancer cells [29].